FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

CUSIP: 31189P102

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
122,342,805
Total 13F shares
14,071,764
Share change
-1,743,802
Total reported value
$23,921,000
Price per share
$1.70
Number of holders
37
Value change
-$3,087,760
Number of buys
11
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
3.5%
4,307,485
$7,753,000 31 Mar 2016
13F
Polaris Venture Management Co. V, L.L.C.
13F
Company
2%
2,473,186
$4,452,000 31 Mar 2016
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
1.8%
2,257,920
$4,064,000 31 Mar 2016
13F
Redmile Group, LLC
13F
Company
1.2%
1,486,980
$2,677,000 31 Mar 2016
13F
ORBIMED ADVISORS LLC
13F
Company
0.57%
692,900
$1,247,000 31 Mar 2016
13F
VANGUARD GROUP INC
13F
Company
0.52%
635,475
$1,144,000 31 Mar 2016
13F
FRANKLIN RESOURCES INC
13F
Company
0.41%
500,000
$900,000 31 Mar 2016
13F
Belmont Global Advisors, Inc.
13F
Company
0.39%
482,000
$868,000 31 Mar 2016
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.39%
474,537
$854,000 31 Mar 2016
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.24%
293,900
$529,000 31 Mar 2016
13F
Board of Trustees of The Leland Stanford Junior University
13F
Company
0.23%
285,953
$515,000 31 Mar 2016
13F
Lombard Odier Asset Management (USA) Corp
13F
Company
0.2%
249,374
$449,000 31 Mar 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.18%
222,700
$401,000 31 Mar 2016
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.17%
204,447
$368,000 31 Mar 2016
13F
Allianz Asset Management GmbH
13F
Company
0.16%
197,329
$355,000 31 Mar 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.14%
173,924
$313,000 31 Mar 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.09%
108,029
$194,000 31 Mar 2016
13F
Telemetry Investments, L.L.C.
13F
Company
0.08%
96,500
$174,000 31 Mar 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.06%
69,394
$125,000 31 Mar 2016
13F
Spark Investment Management LLC
13F
Company
0.05%
63,700
$114,000 31 Mar 2016
13F
Bank of New York Mellon Corp
13F
Company
0.05%
63,428
$114,000 31 Mar 2016
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.05%
61,141
$110,000 31 Mar 2016
13F
BlackRock Fund Advisors
13F
Company
0.05%
59,871
$108,000 31 Mar 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.04%
43,455
$78,000 31 Mar 2016
13F
RUSSELL FRANK CO/
13F
Company
0.03%
39,300
$71,000 31 Mar 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.03%
36,697
$66,000 31 Mar 2016
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
28,228
$51,000 31 Mar 2016
13F
NORTHERN TRUST CORP
13F
Company
0.02%
25,531
$46,000 31 Mar 2016
13F
Nationwide Fund Advisors
13F
Company
0.02%
22,578
$41,000 31 Mar 2016
13F
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
0.02%
22,000
$40,000 31 Mar 2016
13F
MORGAN STANLEY
13F
Company
0.02%
20,002
$36,000 31 Mar 2016
13F
Creative Planning
13F
Company
0.01%
17,000
$31,000 31 Mar 2016
13F
Hochman Cole Investment Advisors, Inc.
13F
Company
0.01%
16,341
$29,000 31 Mar 2016
13F
WEDBUSH SECURITIES INC
13F
Company
0.01%
11,500
$21,000 31 Mar 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.01%
8,811
$16,000 31 Mar 2016
13F
BlackRock Japan Co. Ltd
13F
Company
0%
5,909
$11,000 31 Mar 2016
13F
BlackRock Investment Management, LLC
13F
Company
0%
4,327
$8,000 31 Mar 2016
13F
FIRST MANHATTAN CO. LLC.
13F
Company
0%
4,000
$7,000 31 Mar 2016
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
3,263
$6,000 31 Mar 2016
13F
UBS Group AG
13F
Company
0%
2,127
$4,000 31 Mar 2016
13F
Walleye Trading LLC
13F
Company
0%
1,300
$2,000 31 Mar 2016
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,000
$2,000 31 Mar 2016
13F
D.A. DAVIDSON & CO.
13F
Company
0%
720
$1,000 31 Mar 2016
13F

Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2016

As of 30 Jun 2016, FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,071,764 shares. The largest 10 holders included FMR LLC, Polaris Venture Management Co. V, L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., Redmile Group, LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Belmont Global Advisors, Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, Board of Trustees of The Leland Stanford Junior University, and Lombard Odier Asset Management (USA) Corp. This page lists 37 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders
42
Q2 2016 holders
37
Holder diff
-5
Investor Q1 2016 Shares Q2 2016 Shares Share Diff Share Chg % Q1 2016 Value $ Q2 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.